MINI FUTURE ZERTIFIKAT LONG - QIAGEN Share Price

Certificat

DE000TR9R277

Market Closed - Bid/Ask 20:37:39 05/07/2024 BST After market 20:59:55
5.87 EUR +2.62% Intraday chart for MINI FUTURE ZERTIFIKAT LONG - QIAGEN 6.06 +3.24%
Current month-11.04%
1 month-31.08%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
05/07/24 5.87 +2.62%
04/07/24 5.72 -1.04%
03/07/24 5.78 -0.17%
02/07/24 5.79 +0.35%
01/07/24 5.77 -10.26%

Real-time BOERSE MUENCHEN

Last update July 05, 2024 at 08:37 pm

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying QIAGEN N.V.
Issuer HSBC
WKN TR9R27
ISINDE000TR9R277
Date issued 07/11/2019
Strike 32.14
Maturity Unlimited
Parity 1 : 1
Emission price 1.48
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 23.39
Lowest since issue-

Company Profile

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Sector
-
More about the company

Ratings for Qiagen N.V.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Qiagen N.V.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
41.1 USD
Average target price
50.37 USD
Spread / Average Target
+22.54%
Consensus